BioDuro has opened a new laboratory in Shanghai to supply customized drug discovery services to biopharmaceutical clients in Asia Pacific.
The new lab allows the company to better support the business needs of its clients by increasing efficiency during discovery and development, and providing consistency in the stages of development.
Accompanied by 20,000ft2 feet of office space, the 72,000ft2 lab, provides integrated drug metabolism and pharmacokinetic (DMPK), bioanalytical, chemistry, discovery biology and oncology pharmacology services.
BioDuro general manager and chief scientific officer Jasmine Cui said as a fully integrated life science research service provider, BioDuro has an experienced team of researchers and scientists with expertise in a wide range of drug discovery services.
"This new lab will allow us to meet the business needs of our clients more effectively by streamlining the discovery and development process, and continuing to enhance continuity and smooth transitions throughout the stages of development," Cui added.
A state-of-the-art of 110,000ft2 laboratory is also owned by BioDuro in Beijing, China.
